Clinical Trial Update: Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining how structural and myelin abnormalities relate to cognitive impairments in recent-onset schizophrenia before and after treatm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• lurasidone (lurasidone)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN